Medicines in Development for Children 2020 Report

Researching and developing innovative and therapeutically appropriate medicines for children and infants is an important priority for America’s biopharmaceutical research companies. The biopharmaceutical industry is currently developing nearly 600 medicines to meet the unique needs of pediatric patients.